Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Q3 Net Income Falls to $95M as $76M Merger Costs Weigh on Nine-Month Results

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$33.62
Mkt Cap
$7.195B
52W Low
$24.937
52W High
$38.61
52W Position info
35% above low
Off High info
13% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

AXTA sits 35% above its 52-week low of $24.937.

Summary

Axalta's Q3 net income fell to $95 million ($0.44 per share) from $110 million as $76 million of nine-month merger costs weighed on results, while the $500 million of 2027 notes moved into current liabilities pending repayment or refinancing.


Key Events · Earnings and Guidance · AXTA

  • Q3 Profit Slips on Merger Costs

    Net income of $95 million ($0.44 diluted EPS) versus $110 million ($0.51) a year earlier; nine-month net income $275 million versus $319 million.

  • Merger Costs Reach $76 Million

    Nine-month merger and acquisition-related costs were $76 million versus $11 million in the prior year, with only a $1 million tax benefit recognized.

  • 2027 Notes Moved to Current

    The $500 million 2027 Dollar Senior Notes (4.750%, due June 15, 2027) are now classified as current liabilities; Axalta says it expects to repay or refinance them before maturity.

  • Cash Flow Improves, Debt Prepaid

    Nine-month operating cash flow was $355 million versus $305 million, supporting $195 million of prepayments on the 2029 Dollar Term Loans.


Analysis · AXTA · Industrial Applications And Services

Deal costs, not operations, drove the decline: Axalta earned $95 million ($0.44 per diluted share) in the third quarter versus $110 million ($0.51) a year earlier, and nine-month net income fell to $275 million from $319 million. The drag is almost entirely deal-related — $76 million of pre-tax merger and acquisition costs in the first nine months, against $11 million a year ago, with only $1 million of tax benefit recognized on those costs. Operations themselves held up: net sales rose 1.8% to $1.31 billion on currency and acquisitions, and nine-month operating cash flow improved to $355 million from $305 million, funding $195 million of term-loan prepayments. The balance-sheet item that matters most is the $500 million of 2027 senior notes now sitting in current liabilities because Axalta has deliberately not refinanced them; management says it expects to repay or refinance before the June 15, 2027 maturity. With the AkzoNobel merger expected to close in early 2027 and a North American Building Products divestiture announced October 20 to satisfy regulators, the refinancing and the deal closing are the two dates that set the stock's path.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 30.9% of the 1649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXTA was trading at $33.62 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Oct 29, 2026, 1:25 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.87
Real-time Price: $33.60 info
Change: -$0.265 (-0.78%) info
Market Cap: $7.191B info
AXTA
Oct 29, 2026, 7:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.10
Real-time Price: $33.60 info
Change: -$0.500 (-1%) info
Market Cap: $7.191B info
AXTA
Oct 29, 2026, 6:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $33.40
Real-time Price: $33.60 info
Change: +$0.200 (+0.60%) info
Market Cap: $7.191B info
AXTA
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $34.06
Real-time Price: $33.60 info
Change: -$0.460 (-1%) info
Market Cap: $7.191B info
AXTA
Oct 21, 2026, 3:05 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.78
Real-time Price: $33.60 info
Change: -$1.17 (-3%) info
Market Cap: $7.191B info